BioCentury
ARTICLE | Company News

Eisai, Boston University School of Medicine partner to study microglia in AD

February 2, 2018 8:26 PM UTC

Eisai Co. Ltd. (Tokyo:4523) and the Boston University School of Medicine partnered to study the effects of Alzheimer’s disease-associated genetic variants on the behavior of microglia...